Stephen G. Juelsgaard
Direktor/Vorstandsmitglied bei Altrubio, Inc.
Profil
Stephen G.
Juelsgaard currently works at Altrubio, Inc., as Director.
Dr. Juelsgaard also formerly worked at Rio Grande Neurosciences, Inc., as Director, Genentech, Inc., as Secretary, Chief Compliance Officer & EVP from 1985 to 2009, Wilson Sonsini Goodrich & Rosati PC, as Associate, and African Wildlife Foundation, Inc., as Trustee.
Dr. Juelsgaard received his undergraduate degree from Stanford University and graduate degree and doctorate degree from Iowa State University.
Aktive Positionen von Stephen G. Juelsgaard
Unternehmen | Position | Beginn |
---|---|---|
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Stephen G. Juelsgaard
Unternehmen | Position | Ende |
---|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | General Counsel | 01.05.2009 |
Rio Grande Neurosciences, Inc.
Rio Grande Neurosciences, Inc. Hospital/Nursing ManagementHealth Services Rio Grande Neurosciences, Inc. offers neurological and psychiatric therapies. It focuses on developing, acquiring, and licensing non-invasive brain stimulation therapies used to treat pathologies of the central nervous system. The company was founded in 2011 and is headquartered in Santa Fe, NM. | Direktor/Vorstandsmitglied | - |
African Wildlife Foundation, Inc.
African Wildlife Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC. | Direktor/Vorstandsmitglied | - |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Corporate Officer/Principal | - |
Ausbildung von Stephen G. Juelsgaard
Iowa State University | Doctorate Degree |
Stanford University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Wilson Sonsini Goodrich & Rosati PC
Wilson Sonsini Goodrich & Rosati PC Miscellaneous Commercial ServicesCommercial Services Wilson Sonsini Goodrich & Rosati PC provides legal services. Its services include corporate law and governance, public and private offerings of equity and debt securities, mergers and acquisitions, securities class action litigation, intellectual property litigation, antitrust counseling and litigation, joint ventures and strategic alliances, technology licensing and other intellectual property transactions, tax, and employee benefits and employment law. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Commercial Services |
African Wildlife Foundation, Inc.
African Wildlife Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services African Wildlife Foundation, Inc. operates an international conservation organization focused on the African continent. The organization programs and conservation strategies are based on science and designed to protect both the wild lands and wildlife of Africa. The organization was founded in 1961 and is headquartered in Washington, DC. | Commercial Services |
Rio Grande Neurosciences, Inc.
Rio Grande Neurosciences, Inc. Hospital/Nursing ManagementHealth Services Rio Grande Neurosciences, Inc. offers neurological and psychiatric therapies. It focuses on developing, acquiring, and licensing non-invasive brain stimulation therapies used to treat pathologies of the central nervous system. The company was founded in 2011 and is headquartered in Santa Fe, NM. | Health Services |
Altrubio, Inc.
Altrubio, Inc. Internet RetailRetail Trade Altrubio, Inc. is a clinical-stage biotechnology company based in Redwood City, CA. The company specializes in developing novel therapies leveraging immune checkpoint agonism to enhance the function of natural pathways to downregulate an overactivated immune system. Altrubio's pipeline includes two clinical stage product candidates: neihulizumab, an immune checkpoint agonist antibody targeting PSGl-1/CD162 that depletes unwanted activated T cells with proof of mechanism in four autoimmune and inflammatory diseases, and ABGN-107, an antibody-drug conjugate employing a unique enzyme cleavable hydrophilic self-immolative linker and targeting a gastrointestinal tumor antigen. The company was founded in 2000, and the CEO is Judy Chou. | Retail Trade |